Published in PLoS One on February 16, 2011
The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101. PLoS One (2014) 0.89
Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen. J Allergy Clin Immunol (2015) 0.89
Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family. J Allergy Clin Immunol (2015) 0.86
Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis. J Proteome Res (2012) 0.85
Sensitization prevalence, antibody cross-reactivity and immunogenic peptide profile of Api g 2, the non-specific lipid transfer protein 1 of celery. PLoS One (2011) 0.82
Protease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity. Sci Rep (2015) 0.81
Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine. World J Gastroenterol (2014) 0.80
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesis. Allergy (2013) 0.79
Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC. PLoS One (2014) 0.78
Dendritic cell-based in vitro assays for vaccine immunogenicity. Hum Vaccin Immunother (2012) 0.77
The protein structure determines the sensitizing capacity of Brazil nut 2S albumin (Ber e1) in a rat food allergy model. Clin Transl Allergy (2013) 0.76
Heat processing of peanut seed enhances the sensitization potential of the major peanut allergen Ara h 6. Mol Nutr Food Res (2016) 0.75
The Effect of Solar Irradiated Vibrio cholerae on the Secretion of Pro-Inflammatory Cytokines and Chemokines by the JAWS II Dendritic Cell Line In Vitro. PLoS One (2015) 0.75
Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42
How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol (2010) 4.34
Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science (2005) 4.12
Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol (2003) 2.25
Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol (2010) 1.78
Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J Exp Med (2006) 1.77
Antigen aggregation decides the fate of the allergic immune response. J Immunol (2009) 1.64
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med (1996) 1.51
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49
From allergen genes to allergy vaccines. Annu Rev Immunol (2010) 1.46
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol (2005) 1.17
Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol (2002) 1.16
Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes. Mol Immunol (2006) 1.05
Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun (2008) 1.04
Allergen-related approaches to immunotherapy. Pharmacol Ther (2008) 1.02
Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol (2007) 1.01
Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol (2010) 1.00
MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype. J Immunol (2003) 0.99
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release (2010) 0.97
Diverse regulatory roles for lysosomal proteases in the immune response. Eur J Immunol (2009) 0.97
Distinct protease requirements for antigen presentation in vitro and in vivo. J Immunol (2010) 0.92
Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate. J Biol Chem (2008) 0.91
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol (2010) 0.88
Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology (2009) 0.87
The influence of recombinant production on the immunologic behavior of birch pollen isoallergens. PLoS One (2009) 0.86
Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J Immunol (1992) 0.86
Purification and characterization of recombinant Bet v I, the major birch pollen allergen. Immunological equivalence to natural Bet v I. J Biol Chem (1993) 0.86
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Mol Immunol (2006) 0.85
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J (2002) 0.85
Effects of light spectrum in flatbed scanner densitometry of stained polyacrylamide gels. Biotechniques (2007) 0.82
Development of recombinant allergens for diagnosis and therapy. Front Biosci (Elite Ed) (2009) 0.82
Mutational effects on protein folding stability and antigenicity: the case of streptococcal pyrogenic exotoxin A. Clin Immunol (2003) 0.81
Lipocalin allergen Bos d 2 is a weak immunogen. Int Immunol (2002) 0.80
Specific immunotherapy in pollen allergy. Curr Opin Mol Ther (2007) 0.80
Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope. J Pept Sci (2002) 0.80
Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol (2007) 0.79
Genetic allergen modification in the development of novel approaches to specific immunotherapy. Clin Exp Allergy (2009) 0.78
Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol (2003) 1.99
IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw (2011) 1.91
Antigen aggregation decides the fate of the allergic immune response. J Immunol (2009) 1.64
Morphogenetic pathway of spore wall assembly in Saccharomyces cerevisiae. Eukaryot Cell (2004) 1.45
Novel allergens from ancient foods: Man e 5 from manioc (Manihot esculenta Crantz) cross reacts with Hev b 5 from latex. Mol Nutr Food Res (2013) 1.41
IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol (2004) 1.40
Monolithic materials: Promises, challenges, achievements. Anal Chem (2006) 1.36
Monolithic capillary-based ion-selective electrodes. Anal Chem (2005) 1.36
Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem (2012) 1.31
Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol (2006) 1.30
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant (2011) 1.27
Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol (2010) 1.18
Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol (2005) 1.18
IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol (2003) 1.15
Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol (2011) 1.15
Two-dimensional reversed-phase x ion-pair reversed-phase HPLC: an alternative approach to high-resolution peptide separation for shotgun proteome analysis. J Proteome Res (2007) 1.13
Crystallographically mapped ligand binding differs in high and low IgE binding isoforms of birch pollen allergen bet v 1. J Mol Biol (2012) 1.13
Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial). J Clin Psychiatry (2010) 1.11
3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Mol Immunol (2009) 1.09
Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol (2008) 1.08
K14 mRNA reprogramming for dominant epidermolysis bullosa simplex. Hum Mol Genet (2010) 1.08
Absolute myoglobin quantitation in serum by combining two-dimensional liquid chromatography-electrospray ionization mass spectrometry and novel data analysis algorithms. J Proteome Res (2006) 1.07
Dtrlp, a multidrug resistance transporter of the major facilitator superfamily, plays an essential role in spore wall maturation in Saccharomyces cerevisiae. Eukaryot Cell (2002) 1.07
Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics (2012) 1.06
Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol (2011) 1.05
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol (2005) 1.05
Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J Psychiatr Res (2008) 1.05
Statistical learning of peptide retention behavior in chromatographic separations: a new kernel-based approach for computational proteomics. BMC Bioinformatics (2007) 1.05
B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol (2007) 1.05
Nidovirus sialate-O-acetylesterases: evolution and substrate specificity of coronaviral and toroviral receptor-destroying enzymes. J Biol Chem (2004) 1.04
Profiling of human CD4+ T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1. J Allergy Clin Immunol (2013) 1.04
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. FASEB J (2002) 1.03
Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int Arch Allergy Immunol (2005) 1.02
Separation, detection, and identification of peptides by ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry at high and low pH. J Chromatogr A (2005) 1.02
Depression, anxiety, and disturbed sleep in glaucoma. J Neuropsychiatry Clin Neurosci (2013) 1.00
Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol (2010) 1.00
Two novel types of O-glycans on the mugwort pollen allergen Art v 1 and their role in antibody binding. J Biol Chem (2004) 0.99
The design and optimization of RNA trans-splicing molecules for skin cancer therapy. Mol Oncol (2013) 0.99
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol (2004) 0.98
Fermentation of mixed glucose-xylose substrates by engineered strains of Saccharomyces cerevisiae: role of the coenzyme specificity of xylose reductase, and effect of glucose on xylose utilization. Microb Cell Fact (2010) 0.98
SIMPATIQCO: a server-based software suite which facilitates monitoring the time course of LC-MS performance metrics on Orbitrap instruments. J Proteome Res (2012) 0.97
The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex. J Invest Dermatol (2013) 0.97
Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol (2007) 0.96
Response to Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.96
De novo peptide sequencing by tandem MS using complementary CID and electron transfer dissociation. Electrophoresis (2009) 0.95
Nitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cells. PLoS One (2012) 0.95
A novel screening system improves genetic correction by internal exon replacement. Nucleic Acids Res (2011) 0.95
Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol (2002) 0.95
Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat (2009) 0.93
The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential. J Pineal Res (2010) 0.93
A reporter-based screen to identify potent 3' trans-splicing molecules for endogenous RNA repair. Hum Gene Ther Methods (2013) 0.93
Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen. J Allergy Clin Immunol (2011) 0.93
CRR1, a gene encoding a putative transglycosidase, is required for proper spore wall assembly in Saccharomyces cerevisiae. Microbiology (2004) 0.93
Characterization of Bet v 1-related allergens from kiwifruit relevant for patients with combined kiwifruit and birch pollen allergy. Mol Nutr Food Res (2008) 0.93
Humoral and cellular cross-reactivity between Amb a 1, the major ragweed pollen allergen, and its mugwort homolog Art v 6. J Immunol (2011) 0.92
Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins. Proteomics (2011) 0.92
Improving peptide identification in proteome analysis by a two-dimensional retention time filtering approach. J Proteome Res (2009) 0.91
Proteome analysis of Myxococcus xanthus by off-line two-dimensional chromatographic separation using monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass spectrometry. J Proteome Res (2006) 0.91
Comparative sequencing of nucleic acids by liquid chromatography-tandem mass spectrometry. Anal Chem (2002) 0.90
Characterization of some physical and chromatographic properties of monolithic poly(styrene-co-divinylbenzene) columns. J Chromatogr A (2004) 0.90
High-efficiency nano- and micro-HPLC--high-resolution Orbitrap-MS platform for top-down proteomics. Proteomics (2010) 0.90
The T-cell response to Amb a 1 is characterized by 3 dominant epitopes and multiple MHC restriction elements. J Allergy Clin Immunol (2010) 0.89
Interaction of allergens, major histocompatibility complex molecules, and T cell receptors: a 'ménage à trois' that opens new avenues for therapeutic intervention in type I allergy. Int Arch Allergy Immunol (2011) 0.89
Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach. J Allergy Clin Immunol (2009) 0.89
Monolithic capillary columns for liquid chromatography-electrospray ionization mass spectrometry in proteomic and genomic research. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.89
Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells. Blood (2014) 0.89
Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol (2002) 0.89
Decision-making in localized prostate cancer: lessons learned from an online support group. BJU Int (2010) 0.89
IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J Allergy Clin Immunol (2005) 0.88
Separate analysis of DYS385a and b versus conventional DYS385 typing: is there forensic relevance? Int J Legal Med (2004) 0.88
Genome-wide transcriptional responses to a lipid hydroperoxide: adaptation occurs without induction of oxidant defenses. Free Radic Biol Med (2004) 0.88
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol (2010) 0.88
Workflows for automated downstream data analysis and visualization in large-scale computational mass spectrometry. Proteomics (2015) 0.87
Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS One (2012) 0.87
Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology (2009) 0.87
Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy. J Allergy Clin Immunol (2012) 0.87
Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients. Br J Haematol (2010) 0.87
The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gamma. J Invest Dermatol (2007) 0.87
Purification and structural stability of the peach allergens Pru p 1 and Pru p 3. Mol Nutr Food Res (2008) 0.87
Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition. Mol Immunol (2009) 0.87
Automated de novo sequencing of nucleic acids by liquid chromatography-tandem mass spectrometry. J Am Soc Mass Spectrom (2004) 0.87
Hydrophobic, pellicular, monolithic capillary columns based on cross-linked polynorbornene for biopolymer separations. Anal Chem (2002) 0.87
Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis (2008) 0.87
Functional analysis in yeast of the Brix protein superfamily involved in the biogenesis of ribosomes. FEMS Yeast Res (2003) 0.87
Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol (2005) 0.86